Intraindividual variability in busulfan pharmacokinetics in patients undergoing a bone marrow transplant: assessment of a test dose and first dose strategy-Reference-Cited by-同舟云学术

Intraindividual variability in busulfan pharmacokinetics in patients undergoing a bone marrow transplant: assessment of a test dose and first dose strategy

Published:2004-06 Issue:5 Volume:15 Page:453-459
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Lindley Celeste,Shea Thomas,McCune Jeannine,Shord Stacy,Decker Jodi,Harvey Donald,Petros William P.,Garbriel Don,Serody Jonathan,Kirby Suzanne,Wiley Joseph

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference32 articles.

1. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide;Santos;N Engl J Med,1983

2. Is 600 mg/m2 the appropriate dosage of busulfan in children undergoing bone marrow transplantation?;Vassal;Blood,1992

3. The impact of obesity and disease on busulfan oral clearance in adults;Gibbs;Blood,1999

4. Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation;Grochow;Cancer Chemother Pharmacol,1989

5. Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacology;Hassan;Cancer Chemother Pharmacol,1991

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilization of a Population Pharmacokinetic Model to Improve a Busulfan Test‐Dose Strategy in Allogeneic Hematopoietic Cell Transplant Recipients;The Journal of Clinical Pharmacology;2023-06-09

2. Precision Oncology by Point-of-Care Therapeutic Drug Monitoring and Dosage Adjustment of Conventional Cytotoxic Chemotherapies: A Perspective;Pharmaceutics;2023-04-19

3. Stem Cell Transplantation;The Golden Guide to Oncologic Pharmacy;2022

4. Assessment of a Model-Informed Precision Dosing Platform Use in Routine Clinical Care for Personalized Busulfan Therapy in the Pediatric Hematopoietic Cell Transplantation (HCT) Population;Frontiers in Pharmacology;2020-07-02

5. Intra-individual Pharmacokinetic Variability of Intravenous Busulfan in Hematopoietic Stem Cell-Transplanted Children;Clinical Pharmacokinetics;2020-03-11